CVS Health Corporation $CVS Shares Purchased by Osaic Holdings Inc.

Osaic Holdings Inc. raised its holdings in CVS Health Corporation (NYSE:CVS) by 18.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 229,903 shares of the pharmacy operator’s stock after acquiring an additional 35,809 shares during the quarter. Osaic Holdings Inc.’s holdings in CVS Health were worth $15,828,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in CVS. Avion Wealth lifted its stake in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in shares of CVS Health in the second quarter valued at $30,000. Bell Investment Advisors Inc lifted its position in shares of CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the last quarter. Front Row Advisors LLC boosted its stake in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares in the last quarter. Finally, Roxbury Financial LLC raised its position in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on CVS shares. Wells Fargo & Company decreased their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Wolfe Research raised their target price on shares of CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, December 8th. The Goldman Sachs Group lifted their target price on shares of CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Barclays raised their price objective on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Finally, Jefferies Financial Group boosted their target price on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $94.67.

CVS Health Stock Down 0.1%

CVS stock opened at $77.80 on Friday. The company has a 50 day moving average of $79.10 and a two-hundred day moving average of $72.28. The company has a market cap of $98.76 billion, a price-to-earnings ratio of 204.74, a PEG ratio of 0.77 and a beta of 0.48. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the prior year, the business posted $1.09 earnings per share. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.